Clinical Trials Directory

Trials / Completed

CompletedNCT01960712

The Role of Transpapillary Stenting in the Treatment of Bile Leakage After Liver Transection.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Karolinska University Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Bile leakage after liver transection is treated by external drainage. The question addressed is whether downstream control by transpapillary stent insertion into distal bile duct can enhance healing.

Detailed description

All patients who present with clinically significant bile leakage after liver resection at postoperative day two or longer are offered the opportunity to become randomized to either continuous external drainage or the addition of transpapillary stent.

Conditions

Interventions

TypeNameDescription
DEVICETranspapillary plastic stent (7-10 Fr)Duodenoscopy plus transpapillary bile cannulation plus stent insertion.

Timeline

Start date
2008-11-01
Primary completion
2017-03-01
Completion
2017-05-01
First posted
2013-10-11
Last updated
2020-10-06

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01960712. Inclusion in this directory is not an endorsement.

The Role of Transpapillary Stenting in the Treatment of Bile Leakage After Liver Transection. (NCT01960712) · Clinical Trials Directory